1-20 of 68
antileukemic agents
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Real-World Treatment Patterns and Comparative Effectiveness Among a Population of Elderly Patients with Acute Myeloid Leukemia (AML)

Bruno C. Medeiros, MD, Sacha Satram-Hoang, Faiyaz Momin, Monika Parisi
Journal: Blood
Blood (2018) 132 (Supplement 1): 835.
https://doi.org/10.1182/blood-2018-99-111267
Published: 2018
Journal Articles

Lessons from Nature: A Novel Class of TET Inhibitors for TET2 Mutant Associated Diseases

Yihong Guan, Anand D. Tiwari, PhD, Metis Hasipek, PhD, Dale Grabowski, BS, Yvonne Parker, Cassandra M. Hirsch, Amy C Graham, BS, MS, Yasunobu Nagata, Bartlomiej P. Przychodzen, Aziz Nazha, Daniel Lindner, MD PhD, Tomas Radivoyevitch, PhD, James G Phillips, PhD, Jaroslaw P. Maciejewski, Babal K. Jha
Journal: Blood
Blood (2018) 132 (Supplement 1): 4345.
https://doi.org/10.1182/blood-2018-99-117186
Published: 2018
Journal Articles

The Relationship between Age and Allogeneic Hematopoietic Stem Cell Transplantation (HSCT) in a Cohort of Older Patients with Acute Myeloid Leukemia (AML)

Bruno C. Medeiros, MD, Sacha Satram-Hoang, Faiyaz Momin, Monika Parisi
Journal: Blood
Blood (2018) 132 (Supplement 1): 3588.
https://doi.org/10.1182/blood-2018-99-111274
Published: 2018
Journal Articles

Increase in Chemotherapy Use and Associated Survival Benefit Among Medicare-Aged Patients with Acute Myeloid Leukemia (AML)

Bruno C. Medeiros, MD, Sacha Satram-Hoang, Faiyaz Momin, Monika Parisi
Journal: Blood
Blood (2018) 132 (Supplement 1): 3591.
https://doi.org/10.1182/blood-2018-99-111281
Published: 2018
Journal Articles

The 3-Drug Combination Treatment ART838, ABT199 Plus Sorafenib Is Effective Against AML Xenografts, Possibly Via Cooperative Targeting of MCL1

Blake S Moses, PhD, Jennifer Fox, PhD, Xiaochun Chen, PhD, Samantha McCullough, BS, Sang Ngoc Tran, BA, Allison Kirkpatrick, BS, Kalyani Kumar, BS, Jeffrey W. Tyner, PhD, Gary H. Posner, PhD, Curt I. Civin, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 4044.
https://doi.org/10.1182/blood-2018-99-113040
Published: 2018
Journal Articles

Adjusting Dosage of Mercaptopurine By NUDT15 Polymorphisms in Childhood Acute Lymphoblastic Leukemia

Der-Shiun Wang, MD, Chih-Hsiang Yu, Ph. D student, Wen-Chien Chou, MD, PhD, Ya-Hsuan Chang, Chien-Yu Lin, Kai-Hsin Lin, Shiann-Tarng Jou, MD PhD, Meng Yao Lu, MD, Hsiu-Hao Chang, MD PhD, Shu-Wha Lin, PhD, Dong-Tsamn Lin, Professor, Hsuan-Yu Chen, Ph. D, Yung-Li Yang, MD PhD
Journal: Blood
Blood (2017) 130 (Supplement 1): 2566.
https://doi.org/10.1182/blood.V130.Suppl_1.2566.2566
Published: 2017
Journal Articles

Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel

Clinical Trials & Observations
Hartmut Döhner, Elihu Estey, David Grimwade, Sergio Amadori, Frederick R. Appelbaum, Thomas Büchner, Hervé Dombret, Benjamin L. Ebert, Pierre Fenaux, Richard A. Larson, Ross L. Levine, Francesco Lo-Coco, Tomoki Naoe, Dietger Niederwieser, Gert J. Ossenkoppele, Miguel Sanz, Jorge Sierra, Martin S. Tallman, Hwei-Fang Tien, Andrew H. Wei, Bob Löwenberg, Clara D. Bloomfield
Journal: Blood
Blood (2017) 129 (4): 424–447.
https://doi.org/10.1182/blood-2016-08-733196
Published: 2017
Journal Articles

Decitabine As Salvage Therapy for Relapse of AML and MDS after Allogeneic Stem Cell Transplantation - a Retrospective Multicenter Analysis on Behalf of the German Cooperative Transplant Study Group

Thomas Schroeder, MD, Christina Rautenberg, MD, William Hermann Krüger, MD PhD, Uwe Platzbecker, MD, Gesine Bug, MD, Steinmann Juliane, Stefan A. Klein, MD, Olaf Hopfer, Kathrin Nachtkamp, MD, Ariane Dienst, MD, Mustafa Kondakci, MD, Pia Verena Schmidt, MD, Claudia Heyn, MD, Rainer Haas, MD, Ulrich Germing, Martin Bornhäuser, MD, Guido Kobbe, MD
Journal: Blood
Blood (2016) 128 (22): 3446.
https://doi.org/10.1182/blood.V128.22.3446.3446
Published: 2016
Journal Articles

5-Day Decitabine with Mini Fludarabine and Busulfan Yields Comparable Outcomes to Mini Flu/Bu but with Increased Incidence of Severe Acute GvHD

Melissa Baker, APN, Tracy Andrews, MA, Scott D. Rowley, MD, Andrew L. Pecora, MD, Alan P Skarbnik, MD, David H. Vesole, MD PhD, Andre Goy, MD, Maria Cortes, APN, Angelica Panganiban, RN, Michele L. Donato, MD
Journal: Blood
Blood (2016) 128 (22): 3422.
https://doi.org/10.1182/blood.V128.22.3422.3422
Published: 2016
Journal Articles

Targeting the ER-Mitochondrial Interface of Cell Death Sensitizes Leukemia Cells Towards Cytostatics

Fabian Koczian, Jan Vomacka, Binje Vick, PhD, Britta F Hettich, Uli Kazmaier, Stephan A Sieber, Irmela Jeremias, MD, Angelika M Vollmar, Simone Braig
Journal: Blood
Blood (2016) 128 (22): 2319.
https://doi.org/10.1182/blood.V128.22.2319.2319
Published: 2016
Journal Articles

HSP70-HSF1 Interplays Has a Role in the Pathogenesis of Chronic Lymphocytic Leukemia and Is a Druggable Target

Federica Frezzato, PhD, Flavia Raggi, MS, Filippo Severin, PhD, Veronica Martini, PhD, Valentina Trimarco, PhD, Leonardo Martinello, MS, Marco Pizzi, MD, Andrea Visentin, MD, Monica Facco, MS, Francesco Piazza, MD, Gianpietro Semenzato, MD, Livio Trentin, MD
Journal: Blood
Blood (2016) 128 (22): 4368.
https://doi.org/10.1182/blood.V128.22.4368.4368
Published: 2016
Journal Articles

Genetics Directing Therapy in Acute Lymphocytic Leukemia: Identifying Risk, Defining Targets

Andrea Biondi, Prof, MD, Giovanni Cazzaniga
Journal: Blood
Blood (2015) 126 (23): SCI-35.
https://doi.org/10.1182/blood.V126.23.SCI-35.SCI-35
Published: 2015
Journal Articles

Disease Risk and Host Factors, Not Transplant Type, Predict Outcome Following Allogeneic Hematopoietic Stem Cell Transplantation for Acute Leukemia

Scott R. Solomon, MD, Connie Sizemore, Xu Zhang, Katelin Connor, Melhem Solh, MD, H. Kent Holland, MD, Lawrence E. Morris, MD, Asad Bashey, MD PhD
Journal: Blood
Blood (2015) 126 (23): 4372.
https://doi.org/10.1182/blood.V126.23.4372.4372
Published: 2015
Journal Articles

Inherited genetic variation in childhood acute lymphoblastic leukemia

Takaya Moriyama, Mary V. Relling, Jun J. Yang
Journal: Blood
Blood (2015) 125 (26): 3988–3995.
https://doi.org/10.1182/blood-2014-12-580001
Published: 2015
Journal Articles

A distinct glucose metabolism signature of acute myeloid leukemia with prognostic value

Wen-Lian Chen, Jing-Han Wang, Ai-Hua Zhao, Xin Xu, Yi-Huang Wang, Tian-Lu Chen, Jun-Min Li, Jian-Qing Mi, Yong-Mei Zhu, Yuan-Fang Liu, Yue-Ying Wang, Jie Jin, He Huang, De-Pei Wu, Yan Li, Xiao-Jing Yan, Jin-Song Yan, Jian-Yong Li, Shuai Wang, Xiao-Jun Huang, Bing-Shun Wang, Zhu Chen, Sai-Juan Chen, Wei Jia
Journal: Blood
Blood (2014) 124 (10): 1645–1654.
https://doi.org/10.1182/blood-2014-02-554204
Published: 2014
Includes: Supplemental data
Journal Articles

Dual PI3K/Akt/mTOR Pathway Inhibitor Potentiate Cytarabine Cytotoxicity For Acute Myeloid Leukemia

Eun Kyung Kim, Hyoung Jin Kang, Hyung Joon Kim, Ji Won Lee, Hyery Kim, Kyung Duk Park, Hee Young Shin, Hyo Seop Ahn
Journal: Blood
Blood (2013) 122 (21): 1289.
https://doi.org/10.1182/blood.V122.21.1289.1289
Published: 2013
Journal Articles

Preclinical Evaluation of Oncolytic Reovirus in Targeted Therapeutics for High-Risk Pediatric Leukemia

Matthew F. Clarkson, Aru Narendran, MD, PhD, Randal N. Johnston, PhD
Journal: Blood
Blood (2012) 120 (21): 3571.
https://doi.org/10.1182/blood.V120.21.3571.3571
Published: 2012
Journal Articles

Second Neoplasms After Treatment of Childhood Acute Lymphoblastic Leukemia

Kjeld Schmiegelow, Mette Levinsen, Andishe Attarbashi, Andre Baruchel, Meenakshi Devidas, PhD, Gabriele Escherich, MD, Brenda Gibson, Christiane Heydrich, Keizo Horibe, MD, Yasushi Ishida, Der-Cherng Liang, MD, Franco Locatelli, Prof, MD, PhD, Gerard Michel, Rob Pieters, MD, PhD, Caroline Piette, Ching-Hon Pui, MD, Susana C. Raimondi, Lewis B. Silverman, MD, Martin Stanulla, MD, MSc, Batia Stark, Naomi Winick, MD, Maria Grazia Valsecchi
Journal: Blood
Blood (2012) 120 (21): 661.
https://doi.org/10.1182/blood.V120.21.661.661
Published: 2012
Journal Articles

LFB-R603, a Third-Generation Monoclonal Anti-CD20 Antibody Displays An Additive Antitumor Activity with Antileukemic Chemotherapeutic Agents in Mouse Xenograft Models

Isabel Tourais Esteves, Ph. D., Charles Dumontet, M. D., Ph. D., Stéphanie Herveau, Lina Reslan, Ph. D., Frédérique Brune, Pharm. D., Laurence Van Overtvelt, Ph. D., Margarita Salcedo, PhD, Bénédicte Fournès, Ph. D.
Journal: Blood
Blood (2011) 118 (21): 1660.
https://doi.org/10.1182/blood.V118.21.1660.1660
Published: 2011
Journal Articles

SLCO1B1 Variation and Methotrexate Disposition in Children with Acute Lymphoblastic Leukemia: The Importance of Rare Variants in Pharmacogenetics

Laura B. Ramsey, PhD, Gitte H Bruun, Wenjian Yang, PhD, Lisa R Trevino, PhD, Selina Vattathil, Paul Scheet, PhD, Cheng Cheng, PhD, Gary Rosner, Kathleen Giacomini, PhD, Yiping Fan, PhD, Alex Sparreboom, PhD, Torben Mikkelsen, MD PhD, Thomas J Corydon, PhD, Ching-Hon Pui, MD, William E. Evans, PharmD, Mary V. Relling, PharmD
Journal: Blood
Blood (2011) 118 (21): 571.
https://doi.org/10.1182/blood.V118.21.571.571
Published: 2011